These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15568584)

  • 1. Prescribing trends for nicotine replacement therapy in primary care.
    Tilson L; Bennett K; Barry M
    Ir Med J; 2004 Oct; 97(9):270-3. PubMed ID: 15568584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England.
    Szatkowski L; Coleman T; McNeill A; Lewis S
    Addiction; 2011 Oct; 106(10):1827-34. PubMed ID: 21561500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GP prescribing of nicotine replacement and bupropion to aid smoking cessation in England and Wales.
    McEwen A; West R; Owen L
    Addiction; 2004 Nov; 99(11):1470-4. PubMed ID: 15500600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking cessation treatment in primary care: prospective cohort study.
    Wilson A; Hippisley-Cox J; Coupland C; Coleman T; Britton J; Barrett S
    Tob Control; 2005 Aug; 14(4):242-6. PubMed ID: 16046686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial uptake and evidence of safe prescribing practice with Buproprion (Zyban).
    Williams D; Bennett K; Heery A; Feely J
    Pharmacoepidemiol Drug Saf; 2004 Jun; 13(6):411-5. PubMed ID: 15170772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
    Lutsenko H; Doran CM; Hall WD
    Drug Alcohol Rev; 2008 Mar; 27(2):160-4. PubMed ID: 18264876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs to support smoking cessation in UK general practice: are evidence based guidelines being followed?
    Wilson A; Sinfield P; Rodgers S; Hammersley V; Coleman T
    Qual Saf Health Care; 2006 Aug; 15(4):284-8. PubMed ID: 16885254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine replacement prescribing trends in a large psychiatric hospital, before and after implementation of a hospital-wide smoking ban.
    Scharf D; Fabian T; Fichter-DeSando C; Douaihy A
    Nicotine Tob Res; 2011 Jun; 13(6):466-73. PubMed ID: 21464201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of barriers that impede the implementation of nicotine replacement therapy in the acute cardiac care setting.
    May FC; Stocks N; Barton C
    Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):646-50. PubMed ID: 18779735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicians' counseling of patients when prescribing nicotine replacement therapy.
    Shiffman S; Ferguson SG; Hellebusch SJ
    Addict Behav; 2007 Apr; 32(4):728-39. PubMed ID: 16875786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination treatment with varenicline and nicotine replacement therapy.
    Ebbert JO; Burke MV; Hays JT; Hurt RD
    Nicotine Tob Res; 2009 May; 11(5):572-6. PubMed ID: 19351781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
    Becker KM; Rose JE; Albino AP
    Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of selectors of nicotine replacement therapy.
    Shiffman S; Di Marino ME; Sweeney CT
    Tob Control; 2005 Oct; 14(5):346-55. PubMed ID: 16183986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of nicotine replacement therapy on postoperative mortality following coronary artery bypass graft surgery.
    Paciullo CA; Short MR; Steinke DT; Jennings HR
    Ann Pharmacother; 2009 Jul; 43(7):1197-202. PubMed ID: 19567657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
    Stapleton JA; Watson L; Spirling LI; Smith R; Milbrandt A; Ratcliffe M; Sutherland G
    Addiction; 2008 Jan; 103(1):146-54. PubMed ID: 18028247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacists on the front line in providing support for nicotine replacement therapy and bupropion purchasers.
    Paul CL; Tzelepis F; Walsh RA; Turner R
    Drug Alcohol Rev; 2007 Jul; 26(4):429-33. PubMed ID: 17564880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National trends in the provision of smoking cessation aids within the Veterans Health Administration.
    Jonk YC; Sherman SE; Fu SS; Hamlett-Berry KW; Geraci MC; Joseph AM
    Am J Manag Care; 2005 Feb; 11(2):77-85. PubMed ID: 15726855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case studies of three pregnant smokers and their use of nicotine replacement therapy.
    Hotham ED; Gilbert AL; Atkinson ER
    Midwifery; 2005 Sep; 21(3):224-32. PubMed ID: 15967546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.